𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy

✍ Scribed by Li Qian; Patrick M. Flood; Jau-Shyong Hong

Publisher
Springer
Year
2010
Tongue
English
Weight
256 KB
Volume
117
Category
Article
ISSN
1435-1463

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroprotective therapy in Parkinson's d
Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy
✍ C. Warren Olanow; Joseph Jankovic 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

The introduction of levodopa in the late 1960s represented a landmark in the therapy of Parkinson's disease (PD). However, motor complications of chronic levodopa therapy have emerged as a major limitation of this otherwise effective therapy. Advancing medical and surgical treatment of these complic

Leucine-rich repeat kinase 2 (LRRK2): A
Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease
✍ Payal N. Gandhi; Shu G. Chen; Amy L. Wilson-Delfosse 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

## Abstract Parkinson's disease (PD) is the most common neurodegenerative movement disorder, with a prevalence of more than 1% after the age of 65 years. Mutations in the gene encoding leucine‐rich repeat kinase‐2 (__LRRK2__) have recently been linked to autosomal dominant, late‐onset PD that is cl

The subthalamic nucleus: A possible targ
The subthalamic nucleus: A possible target for stereotaxic surgery in parkinson's disease
✍ J. Guridi; M. R. Luquin; M. T. Herrero; Dr. J. A. Obeso 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

## Abstract Hyperactivity in the subthalamic nucleus (STN) projections to the globus pallidus medialis (GPM) has been established as a crucial feature of parkinsonism in animal models of Parkinson's disease (PD). Recent experiments blocking the STN glutamatergic output to GPM or lesioning the STN s

Cognitive-behavioral therapy for depress
Cognitive-behavioral therapy for depression in Parkinson's disease: A pilot study
✍ Roseanne DeFronzo Dobkin; Lesley A. Allen; Matthew Menza 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract The present study was conducted to examine the feasibility and effect of an individual cognitive‐behavioral treatment (CBT) for depression that was modified to meet the unique needs of the PD patient and incorporated a separate social support intervention for caregivers. Fifteen PD pati